[
  {
    "abstract_id": "ECO-2026-T1.1",
    "title": "Semaglutide 2.4mg long-term cardiovascular outcomes — Phase 4 SELECT-extension mock",
    "authors": "Mock AP",
    "abstract_text": "Semaglutide 2.4mg long-term Phase 4 mock cardiovascular outcome extension demonstrated sustained -8.9% placebo-adjusted weight loss at 4-year follow-up. GI AE 18.6%. All data synthetic.",
    "phase": "Phase 4",
    "weight_loss_pct": 8.9,
    "gi_ae_pct": 18.6
  },
  {
    "abstract_id": "ECO-2026-T2.4",
    "title": "Liraglutide vs Wegovy in adolescents with obesity — Phase 3 (synthetic)",
    "authors": "Mock AQ, Mock AR",
    "abstract_text": "Phase 3 synthetic adolescent obesity comparison: liraglutide -5.6% vs semaglutide (Wegovy) -10.4% placebo-adjusted weight loss. Mock GI AE 14.1% vs 19.5%. Synthetic data.",
    "phase": "Phase 3",
    "weight_loss_pct": 5.6,
    "gi_ae_pct": 14.1
  },
  {
    "abstract_id": "ECO-2026-T3.7",
    "title": "Cagrilintide monotherapy in obesity — Phase 2b (mock)",
    "authors": "Mock AS",
    "abstract_text": "Cagrilintide (AM833) monotherapy synthetic Phase 2b: -8.0% placebo-adjusted weight loss at 26 weeks, GI AE 17.2%. All data mock.",
    "phase": "Phase 2b",
    "weight_loss_pct": 8.0,
    "gi_ae_pct": 17.2
  },
  {
    "abstract_id": "ECO-2026-T4.2",
    "title": "Naltrexone-bupropion long-term real-world outcomes — Phase 4 mock registry",
    "authors": "Mock AT",
    "abstract_text": "Naltrexone-bupropion (Contrave) Phase 4 synthetic registry showed mean -4.2% weight loss at 24 months, GI AE 9.6%. Mock data, not real registry.",
    "phase": "Phase 4",
    "weight_loss_pct": 4.2,
    "gi_ae_pct": 9.6
  },
  {
    "abstract_id": "ECO-2026-T5.1",
    "title": "ECC5004 oral GLP-1 — Phase 2 dose ranging in obesity (synthetic)",
    "authors": "Mock AU",
    "abstract_text": "ECC5004 (Eccogene / AstraZeneca) Phase 2 synthetic dose-ranging: -7.8% placebo-adjusted weight loss at 12 weeks, GI AE 18.9%. Mock data.",
    "phase": "Phase 2",
    "weight_loss_pct": 7.8,
    "gi_ae_pct": 18.9
  }
]
